RDHL.TA - RedHill Biopharma Ltd.

Tel Aviv - Tel Aviv Delayed Price. Currency in ILS
Income Statement
Balance Sheet
Cash Flow

Income Statement

Currency in USD. All numbers in thousands
Total Revenue10137,014
Cost of Revenue--1,050
Gross Profit10135,964
Operating Expenses
Research Development25,24117,77112,700
Selling General and Administrative5,4034,2343,911
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-30,543-22,002-10,647
Income from Continuing Operations
Total Other Income/Expenses Net1,5481,124319
Earnings Before Interest and Taxes-28,995-20,878-10,328
Interest Expense375212383
Income Before Tax-29,370-21,090-10,711
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-29,370-21,090-10,711
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-29,370-21,090-10,711
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-29,370-21,090-10,711